Powered by: Motilal Oswal
2026-02-24 12:20:21 pm | Source: Accord Fintech
India shifts from `pharmacy of the world` to `innovator of the world`: Jagat Prakash Nadda
India shifts from `pharmacy of the world` to `innovator of the world`: Jagat Prakash Nadda

India’s pharmaceutical journey is witnessing a paradigm shift. According to Union Minister for Chemicals and Fertilizers, Jagat Prakash Nadda, India is transitioning from ‘pharmacy of the world’ to an ‘innovator of the world’, on the back of a strong focus on healthcare security, manufacturing resilience, and scientific excellence. Minister credited the leadership of Prime Minister Narendra Modi for this journey.

Nadda further underscored India’s growing leadership in the global pharmaceutical sector and its commitment to quality, innovation, and healthcare security, adding that India must anchor global supply chains not only through scale but also through quality, reliability, and innovation. Referring to key government initiatives, Nadda also underlined that India’s policy framework is aligned with this transformation.

Besides, Minister highlighted the role of emerging technologies, particularly responsible use of artificial intelligence, in strengthening predictive diagnostics, pharmaceutical traceability, pharmacovigilance, and overall quality systems. Calling upon industry stakeholders, he stressed that quality must be embedded as a core organizational value rather than treated merely as a compliance requirement.

He also emphasized the need for continued investment in human resources, systems, and infrastructure to build a sustainable quality-first ecosystem. The Minister reiterated India’s vision to emerge as a global pharmaceutical leader that combines scale with trust, innovation with collaboration, and growth with responsibility, thereby contributing significantly to global healthcare outcomes.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here